The current IMRX market cap is 51.83M. The company's latest EPS is USD -1.8260 and P/E is -0.97.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 38k | 1,000 | 0 | 0 | 0 |
Operating Income | -13.19M | -13.99M | -14.68M | -13.51M | -13.93M |
Net Income | -12.84M | -13.25M | -13.6M | -12.19M | -12.6M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.92M | 2.31M | 2.08M | 317k | 0 |
Operating Income | -6.29M | -17.08M | -33.89M | -51.75M | -58.41M |
Net Income | -7.71M | -17.04M | -33.54M | -50.51M | -53.47M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 133.69M | 122.37M | 107.7M | 124.9M | 113.88M |
Total Liabilities | 11.8M | 12.52M | 9.91M | 9.79M | 9.86M |
Total Equity | 121.89M | 109.85M | 97.79M | 115.1M | 104.02M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 14.1M | 38.42M | 166.71M | 122.37M | 102.59M |
Total Liabilities | 4.02M | 2.8M | 10.73M | 12.52M | 12.01M |
Total Equity | -6.53M | -22.48M | 155.98M | 109.85M | 90.58M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -32.35M | -44.1M | -14.42M | -25.17M | -37.19M |
Investing | 33.68M | 41.83M | 18.97M | 28.14M | 4.16M |
Financing | 204k | 19k | 239k | 28.41M | 28.43M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -4.44M | -14.62M | -30.85M | -44.1M | -48.97M |
Investing | -21k | -53k | -75.62M | 41.83M | 7.3M |
Financing | 17.17M | 37.98M | 144.27M | 19k | 28.44M |
Market Cap | 51.83M |
Price to Earnings Ratio | -0.97 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.87 |
Price to Book Ratio | 0.57 |
Dividend Yield | - |
Shares Outstanding | 29.28M |
Average Volume (1 week) | 449.71k |
Average Volume (1 Month) | 645.06k |
52 Week Change | -87.53% |
52 Week High | 14.29 |
52 Week Low | 1.75 |
Spread (Intraday) | 0.09 (4.79%) |
Company Name | Immuneering Corporation |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.immuneering.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.